Clinuvel Pharmaceuticals Ltd (CUV) — Cash Flow-to-Debt Ratio
Clinuvel Pharmaceuticals Ltd (CUV) has a Cash Flow-to-Debt Ratio of 0.61x as of December 2025, meaning its operating cash flow of AU$12.52 Million could theoretically repay 1% of its total liabilities (AU$20.68 Million) in one year. See CUV FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clinuvel Pharmaceuticals Ltd Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Clinuvel Pharmaceuticals Ltd across 24 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Clinuvel Pharmaceuticals Ltd.
Annual Cash Flow-to-Debt Ratio for Clinuvel Pharmaceuticals Ltd (2001–2025)
Year-by-year debt coverage analysis for Clinuvel Pharmaceuticals Ltd. Check Clinuvel Pharmaceuticals Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.33x | AU$41.10 Million | AU$30.94 Million | ▲ +0.8% |
| 2024 | 1.32x | AU$37.05 Million | AU$28.11 Million | ▲ +6.7% |
| 2023 | 1.23x | AU$36.91 Million | AU$29.89 Million | ▼ -40.4% |
| 2022 | 2.07x | AU$39.87 Million | AU$19.25 Million | ▲ +5.7% |
| 2021 | 1.96x | AU$19.26 Million | AU$9.83 Million | ▲ +30.9% |
| 2020 | 1.50x | AU$14.19 Million | AU$9.48 Million | ▼ -58.1% |
| 2019 | 3.57x | AU$18.46 Million | AU$5.17 Million | ▲ +6.6% |
| 2018 | 3.35x | AU$11.69 Million | AU$3.49 Million | ▲ +6.9% |
| 2017 | 3.14x | AU$9.92 Million | AU$3.16 Million | ▲ +243.4% |
| 2016 | -2.19x | AU$-5.04 Million | AU$2.30 Million | ▼ -17.7% |
| 2015 | -1.86x | AU$-4.53 Million | AU$2.44 Million | ▲ +33.3% |
| 2014 | -2.79x | AU$-4.81 Million | AU$1.73 Million | ▲ +20.1% |
| 2013 | -3.49x | AU$-6.89 Million | AU$1.98 Million | ▲ +17.9% |
| 2012 | -4.25x | AU$-10.02 Million | AU$2.36 Million | ▼ -68.3% |
| 2011 | -2.52x | AU$-9.49 Million | AU$3.76 Million | ▲ +34.0% |
| 2010 | -3.82x | AU$-11.78 Million | AU$3.08 Million | ▼ -58.9% |
| 2009 | -2.41x | AU$-10.99 Million | AU$4.56 Million | ▼ -5.8% |
| 2008 | -2.28x | AU$-7.18 Million | AU$3.16 Million | ▲ +32.3% |
| 2007 | -3.36x | AU$-8.18 Million | AU$2.43 Million | ▲ +9.1% |
| 2006 | -3.70x | AU$-11.40 Million | AU$3.08 Million | ▼ -4.1% |
| 2005 | -3.55x | AU$-9.25 Million | AU$2.60 Million | ▲ +17.5% |
| 2004 | -4.31x | AU$-6.00 Million | AU$1.39 Million | ▲ +63.5% |
| 2002 | -11.81x | AU$-2.49 Million | AU$210.83K | ▼ -630.6% |
| 2001 | -1.62x | AU$-514.54K | AU$318.26K | — |